An interventional study of tDCS in Auditory Verbal Hallucinations and Schizophrenia, sponsored by Charite University, Berlin, Germany. Completed at 2 sites in Germany. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2016-08-16.
Sponsored by Charite University, Berlin, Germany · Not applicable, Interventional, and Treatment
The current study investigates the basic principles that underlie the efficacy of transcranial direct current stimulation for chronic auditory verbal hallucinations in schizophrenia in a multimodal design.
135 studies on the registry are indexed under Hallucinations; 36 are open to participants now.
This study's enrollment of 30 is below the median of 50 across 115 interventional studies indexed under Hallucinations.
Browse Hallucinations studies →Charite University, Berlin, Germany is the lead sponsor of 854 studies on the registry; 127 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
left-hemispheric tDCS: anode placed midway between F3 and FP1, cathode placed midway between T3 and P3
Device: tDCS
left-hemispheric sham tDCS: anode placed midway between F3 and FP1, cathode placed midway between T3 and P3
Device: tDCS
active vs. sham tDCS left hemisphere
Also known as: device: neuroConn tDCS PLUS device
Change of Auditory Hallucination Rating Scale score
Auditory Hallucination Rating Scale score will be assessed at baseline; changes thereof at 3 days after intervention and 3 months after intervention are primary outcome measures
Time frame: baseline; 3 days after intervention; 3 months after intervention
Positive And Negative Syndrome Scale
Positive And Negative Syndrome Scale score will be assessed at baseline; changes thereof at 3 days after intervention and 3 months after intervention are secondary outcome measures
Time frame: baseline; 3 days after intervention; 3 months after intervention
N1 suppression during talking and listening
N1 suppression during talking and listening will be assessed at baseline; change thereof at 3 days after intervention is further outcome measure
Time frame: baseline; 3 days after intervention
Diffusion Tensor Imaging: Fractional anisotropy of longitudinal superior fascicle and arcuate fascicle
Fractional anisotropy of longitudinal superior fascicle and arcuate fascicle will be assessed at baseline; change thereof 3 days after intervention is further outcome measure
Time frame: baseline; 3 days after intervention
Default Mode Network connectivity
Default Mode Network connectivity will be assessed at baseline; change thereof 3 days after intervention is further outcome measure
Time frame: baseline; 3 days after intervention
The record gives a start of Mar 2013, a primary completion of Dec 2015 and a completion of Dec 2015. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Charite University, Berlin, Germany →